Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kalaris Therapeutics, Inc. | 453,529 | reported | 04 Oct 2021 | tx 14+345,700−121,586 |
| Forma Therapeutics Holdings, Inc., | 0 | reported | 14 Oct 2022 | tx 4+197,000−197,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Oct 2022 | TENDER | Forma Therapeutics Holdings, Inc., | 79,000 | — | |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 118,000 | — | deriv |
| 11 Jul 2022 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 79,000 | 0.00 USD | |
| 11 Jul 2022 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 118,000 | 0.00 USD | deriv |
| 04 Oct 2021 | SALE | Kalaris Therapeutics, Inc. | 10,678 | 23.29 USD | |
| 04 Oct 2021 | SALE | Kalaris Therapeutics, Inc. | 333 | 26.02 USD | |
| 04 Oct 2021 | SALE | Kalaris Therapeutics, Inc. | 2,967 | 25.41 USD | |
| 04 Oct 2021 | SALE | Kalaris Therapeutics, Inc. | 4,711 | 24.23 USD | |
| 28 Sept 2021 | SALE | Kalaris Therapeutics, Inc. | 3,750 | 24.12 USD | |
| 15 Sept 2021 | SALE | Kalaris Therapeutics, Inc. | 800 | 24.03 USD | |
| 02 Jul 2021 | SALE | Kalaris Therapeutics, Inc. | 18,586 | 19.99 USD | |
| 05 Apr 2021 | SALE | Kalaris Therapeutics, Inc. | 18,212 | 23.89 USD | |
| 17 Sept 2021 | SALE | Kalaris Therapeutics, Inc. | 2,950 | 24.01 USD | |
| 22 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 3,750 | 25.97 USD | |
| 02 Feb 2021 | SALE | Kalaris Therapeutics, Inc. | 54,849 | 41.19 USD | |
| 19 Jan 2021 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 43,750 | 0.00 USD | |
| 19 Jan 2021 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 81,250 | 0.00 USD | deriv |
| 29 Jul 2020 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 220,700 | 0.00 USD | deriv |